Escherichia coli antimicrobial resistance increased faster among geriatric outpatients compared with adult outpatients in the USA, 2000-10

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 8, 2013, Pages 1838-1841

  Sanchez, Guillermo V ^a   Adams, Spencer J E ^b   Baird, Alexis M G ^a   Master, Ronald N ^c   Clark, Richard B ^c   Bordon, Jose M ^d  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^d Providence Hospital Washington DC   (United States)

Author keywords

Antibiotic resistance; Elderly; Surveillance; The surveillancenetwork; Urinary tract infections

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALOTIN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DISEASE SURVEILLANCE; EMERGENCY WARD; ESCHERICHIA COLI; FEMALE; GROUPS BY AGE; HUMAN; IN VITRO STUDY; MALE; NONHUMAN; OUTPATIENT; UNITED STATES; URINARY TRACT INFECTION;

ANTIBIOTIC RESISTANCE; ELDERLY; SURVEILLANCE; THE SURVEILLANCE NETWORK; URINARY TRACT INFECTIONS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OUTPATIENTS; PREVALENCE; UNITED STATES; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84880719775     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt110     Document Type: Article

References (12)

1. Talan DA, Stamm WE, Hooton TM et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA 2000; 283: 1583-90.
2. Hooton TM, Besser R, Foxman B et al. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 2004; 39: 75-80.
3. Nicolle LE. Urinary tract infections in the elderly. Clin Geriatr Med 2009; 25: 423-36.
4. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol 2010; 7: 653-60.
5. Ruben FL, Dearwater SR, Norden CW et al. Clinical infections in the noninstitutionalized geriatric age group: methods utilized and incidence of infections. The Pittsburgh Good Health Study. Am J Epidemiol 1995; 141: 145-57.
6. Shortliffe LMD, McCue JD. Urinary tract infection at the age extremes: pediatrics and geriatrics. Am J Med 2002; 113 Suppl 1: 55-66.
7. Sahm DF, Marsilio MK, Piazza G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with The Surveillance Network Database-USA. Clin Infect Dis 1999; 29: 259-63.
8. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 2003; 36: 14337.
9. Gomolin IH, Siami PF, Reuning-Scherer J et al. Efficacy and safety of ciprofloxacin oral suspension versus trimethoprimsulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection. J Am Geriatr Soc 2001; 49: 160613.
10. Samsioe G. Urogenital aging-a hidden problem. Am J Obstet Gynecol 1998; 178: S2459.
11. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 2002; 8: 34754.
12. Beveridge LA, Davey PG, Phillips G et al. Optimal management of urinary tract infections in older people. Clin Interv Aging 2011; 6: 17380.